Free Trial 中
Wind ESG Rating

Access to ESG rating for China A-Shares and Hong Kong listed companies.

美迪西

688202.SH
Wind Industry: 医疗保健 > 医药生物 > 生命科学工具和服务Ⅲ > 生命科学工具和服务Ⅳ

公司是一家专业的生物医药临床前综合研发服务CRO公司，致力于为全球的医药企业和科研机构提供全方位的符合国内及国际申报标准的一站式新药研发服务。公司服务涵盖医药临床前新药研究的全过程，主要包括药物发现、药学研究及临床前研究三大板块，协助客户快速、高效地完成新药研发临床前研究各个阶段。经过二十年的发展，美迪西现已拥有超过8.4万平方米的研发办公场地，公司各业务板块主要负责人员由几位经验丰富的华裔博士和在国内制药领域工作多年的博士组成。公司先后被认定为“上海市高新技术企业”、“技术先进型服务企业”、“上海市研发公共服务平台”、“浦东新区企业研发机构”，获批设立“上海浦东新区企业博士后工作站”、“院士专家工作站”等。秉承“全球视野，质量至上”的经营理念，未来美迪西将牢牢把握医药研发服务行业的发展机遇，加强公司在化学、生物、原料药、制剂和临床前研究领域的专业服务能力，通过提供高质量全方位的服务，将公司建设成为一家具有国际竞争实力的大型研究服务企业。

ESG Score Industry Ranking:
7 / 36 (生命科学工具和服务Ⅲ)

ESG Rating Distribution(生命科学工具和服务Ⅲ)

Trend of Rating

2022-04-14: BBB; 2023-06-13: BBB; 2024-05-24: BBB; 2025-05-16: A; 2026-07-21: AA BBB2022.04 BBB2023.06 BBB2024.05 A2025.05 AA2026.07

About Wind ESG Rating

Wind has developed a rigorous rating methodology based on the core connotations of ESG, aligning with international standards and frameworks, and incorporating the characteristics of Chinese companies, to assess the company's essential ESG performance, risk and its ability to operate sustainably.

Focusing on the ESG risks and opportunities of each industry, the companies are rated on a AAA-CCC scale relative to the performance of their industry peers. Wind ESG rating is updated annually or in response to major changes.

The Wind ESG Rating Issuer Communication Platform (esg.wind.com.cn) is now available. Rated companies can access their detailed rating information through this platform, and communicate with or provide feedback to the Wind ESG Rating team regarding specific rating components. For any additional questions, please feel free to send an email to GR.ESG@wind.com.cn.

ESG Score

ESG Score：8.19Updated on 2026-10-29
08.1910
Management & Practices Score：5.22Updated on 2026-09-16
05.227
Controversies Score：2.97Updated on 2026-10-29
02.973

ESG Score Comparison

Environmental Social Governance 美迪西生命科学工具和服务Ⅲ Average
IndicatorCompany ScoreIndustry AverageWeight
Environmental5.243.7915.43%
Social7.935.1558.35%
Governance7.686.3326.22%

Wind ESG Rating Framework

Building on the foundation of domestic and international ESG policies and standards, our proprietary ESG rating framework considers the development of Chinese capital market and integrates the characteristics of the Chinese companies in various industries. The Wind ESG Rating framework is composed of management & practice and controversies assessment, including:

  • 500+ management & practices indicators, covering E, S and G pillars, reflecting long-term ESG fundamental impacts
  • 1,200+ risk labels, covering news, regulatory penalties and lawsuits, reflecting impact of short-term risks

Management & practice score is the weighted summation of E, S and G pillar scores. The weights reflect both the relative impact of each issue within each industry and the negative or positive contribution of each industry to the environment and society relative to other industries.

Controversies score and ESG score are updated daily, E, S and G pillar scores and management & practice score are updated with underlying data, corresponding data are released on various channels, including Wind Financial Terminal.

Explore More

Wind ESG Rating Methodology.pdf1,198KB Wind ESG Ratings FAQs.pdf755KB
More Details

Peer Comparison(36 companies in the industry) ?

RankingCodeSecurity NameESG RatingESG ScoreControversies ScoreManagement & Practices ScoreEnvironmentalSocialGovernance
1688114.SH华大智造AA8.822.985.856.928.778.25
2300725.SZ药石科技AA8.523.005.528.877.338.55
3002821.SZ凯莱英A8.442.985.476.417.968.30
4301230.SZ泓博医药AA8.332.975.366.798.137.13
5688131.SH皓元医药AA8.312.995.316.307.847.79
6688238.SH和元生物AA8.212.785.434.788.617.58
7688202.SH美迪西AA8.192.975.225.247.937.68
8688222.SH成都先导AA8.112.995.126.027.597.46
9300759.SZ康龙化成AA8.052.935.127.677.436.83
9603259.SH药明康德AA8.052.995.077.746.568.46